Dr Mitchell D. Weinberg discusses the advantages of the FlowTriever system (Inari Medical) and how mechanical thrombectomy is evolving within the field of interventional cardiology.
Dr Mitchell D. Weinberg discusses the advantages of the FlowTriever system (Inari Medical) and how mechanical thrombectomy is evolving within the field of interventional cardiology.
Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.
Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.
Kyle S. Stumetz, DO, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, DO, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Jason Levy, MD, FSIR, discusses the clinical considerations, procedural techniques, and ongoing evidence in the use of percutaneous ablation for treating vertebral metastases.
Jason Levy, MD, FSIR, discusses the clinical considerations, procedural techniques, and ongoing evidence in the use of percutaneous ablation for treating vertebral metastases.
Dr Chaar provides an overview of the Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) trial, which assesses the safety and efficacy of the VenoValve device.
Dr Chaar provides an overview of the Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) trial, which assesses the safety and efficacy of the VenoValve device.
Dr Heather McArthur speaks about her work examining the impact of preoperative cryoablation and immune checkpoint inhibition on 3-year event-free survival in women with TNBC after taxane-based neoadjuvant chemotherapy.
Dr Heather McArthur speaks about her work examining the impact of preoperative cryoablation and immune checkpoint inhibition on 3-year event-free survival in women with TNBC after taxane-based neoadjuvant chemotherapy.
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients.
FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients.
FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
Atrial fibrillation is rising at an alarming pace, and its clinical impact continues to deepen. Atrial fibrillation continues to expand in scale and complexity, with the Centers for Disease Control and Prevention estimating that 12.1...
Atrial fibrillation is rising at an alarming pace, and its clinical impact continues to deepen. Atrial fibrillation continues to expand in scale and complexity, with the Centers for Disease Control and Prevention estimating that 12.1...
New York, New York -- November 2025 -- Patrick E. Muck, MD, RVT, of TriHealth-Good Samaritan Hospital in Cincinnati, Ohio, presented new findings at the 2025 VEITHsymposium demonstrating that endovascular aortic repair (EVAR) can be...
New York, New York -- November 2025 -- Patrick E. Muck, MD, RVT, of TriHealth-Good Samaritan Hospital in Cincinnati, Ohio, presented new findings at the 2025 VEITHsymposium demonstrating that endovascular aortic repair (EVAR) can be...
